Go Back

Literature in Oncology: Bone Tumours

Newman EN, Jones RL, Hawkins DS.

An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing sarcoma.

Pediatr Blood Cancer. 2013 Jul;60(7):1113-7


Treglia G, Salsano M, Stefanelli A, Mattoli MV, Giordano A, Bonomo L.

Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis.

Skeletal Radiol. 2012 Mar;41(3):249-56. doi: 10.1007/s00256-011-1298-9. Epub 2011 Nov 10.


Samarin A, Burger C, Wollenweber SD, Crook DW, Burger IA, Schmid DT, von Schulthess GK, Kuhn FP.

PET/MR imaging of bone lesions--implications for PET quantification from imperfect attenuation correction.

Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1154-60.


Talbot JN, Paycha F, Balogova S.

Diagnosis of bone metastasis: recent comparative studies of imaging modalities.

Q J Nucl Med Mol Imaging. 2011 Aug;55(4):374-410.


Czernin J, Satyamurthy N, Schiepers C.

Molecular mechanisms of bone 18F-NaF deposition.

J Nucl Med. 2010 Dec;51(12):1826-9.


Moharir M, London K, Howman-Giles R, North K.

Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1.

Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1309-17.


Fellner M, Baum RP, Kubícek V, Hermann P, Lukes I, Prasad V, Rösch F.

PET/CT imaging of osteoblastic bone metastases with (68)Ga-bisphosphonates: first human study.

Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):834.


Balamuth NJ, Womer RB.

Ewing's sarcoma.

Lancet Oncol. 2010 Feb;11(2):184-92.


Nguyen NC, Chaar BT, Osman MM.

Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET/CT.

BMC Med Imaging. 2007 Dec 12;7:8.


PDFFree pdf

Völker T, Denecke T, Steffen I, Misch D, Schönberger S, Plotkin M, Ruf J, Furth C, Stöver B, Hautzel H, Henze G, Amthauer H.

Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.

J Clin Oncol. 2007 Dec 1;25(34):5435-41.


Even-Sapir E, Mishani E, Flusser G, Metser U.

18F-Fluoride positron emission tomography and positron emission tomography/computed tomography.

Semin Nucl Med. 2007 Nov;37(6):462-9.


Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R.

Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.

Pediatr Blood Cancer. 2007 Dec;49(7):901-5.


Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I.

The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.

J Nucl Med. 2006 Feb;47(2):287-97.


PDFFree pdf

Even-Sapir E.

Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities.

J Nucl Med. 2005 Aug;46(8):1356-67.


PDFFree pdf

Even-Sapir E, Metser U, Flusser G, Zuriel L, Kollender Y, Lerman H, Lievshitz G, Ron I, Mishani E.

Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.

J Nucl Med. 2004 Feb;45(2):272-8.



Philip T, Blay JY, Brunat-Mentigny M, Carrie C, Chauvot P, Farsi F, Fervers B, Gentet JC, Giammarile F, Kohler R, Mathoulin S, Patricot LM, Thiesse P; French National Federation of Cancer (FNCLCC).

Br J Cancer. 2001 May;84 Suppl 2:78-80.